,48 Indeed, our CD4 and CD8 depletion study revealed that the efficacy of this oral cancer vaccine greatly relies on the function of both CD4+ and CD8+ T cells (Figure 4). The gene discussed is CD4; the disease is lip and oral cavity carcinoma.